Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection
- PMID: 18097046
- DOI: 10.4049/jimmunol.180.1.444
Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection
Abstract
Immunization with Plasmodium yoelii merozoite surface protein (PyMSP)-8 protects mice from lethal malaria but does not prevent infection. Using this merozoite surface protein-based vaccine model, we investigated vaccine- and infection-induced immune responses that contribute to protection. Analysis of prechallenge sera from rPyMSP-8-immunized C57BL/6 and BALB/c mice revealed high and comparable levels of Ag-specific IgG, but differences in isotype profile and specificity for conformational epitopes were noted. As both strains of mice were similarly protected against P. yoelii, we could not correlate vaccine-induced responses with protection. However, passive immunization studies suggested that protection resulted from differing immune responses. Studies with cytokine-deficient mice showed that protection was induced by immunization of C57BL/6 mice only when IL-4 and IFN-gamma were both present. In BALB/c mice, the absence of either IL-4 or IFN-gamma led to predictable shifts in the IgG isotype profile but did not reduce the magnitude of the Ab response induced by rPyMSP-8 immunization. Immunized IL-4-/- BALB/c mice were solidly protected against P. yoelii. To our surprise, immunized IFN-gamma-/- BALB/c mice initially controlled parasite growth but eventually succumbed to infection. Analysis of cytokine production revealed that P. yoelii infection induced two distinct peaks of IFN-gamma that correlated with periods of controlled parasite growth in intact, rPyMSP-8-immunized BALB/c mice. Maximal parasite growth occurred during a period of sustained TGF-beta production. Combined, the data indicate that induction of protective responses by merozoite surface protein-based vaccines depends on IL-4 and IFN-gamma-dependent pathways and that vaccine efficacy is significantly influenced by host responses elicited upon infection.
Similar articles
-
Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.Infect Immun. 2007 Mar;75(3):1349-58. doi: 10.1128/IAI.01467-06. Epub 2006 Dec 11. Infect Immun. 2007. PMID: 17158895 Free PMC article.
-
Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.Infect Immun. 2004 Oct;72(10):5605-12. doi: 10.1128/IAI.72.10.5605-5612.2004. Infect Immun. 2004. PMID: 15385457 Free PMC article.
-
Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.Infect Immun. 2019 Sep 19;87(10):e00236-19. doi: 10.1128/IAI.00236-19. Print 2019 Oct. Infect Immun. 2019. PMID: 31308085 Free PMC article.
-
Immunity to erythrocytic stages of malarial parasites.Am J Trop Med Hyg. 1994;50(4 Suppl):27-32. doi: 10.4269/ajtmh.1994.50.27. Am J Trop Med Hyg. 1994. PMID: 7909653 Review.
-
Immune responses to liver-stage parasites: implications for vaccine development.Chem Immunol. 2002;80:97-124. doi: 10.1159/000058841. Chem Immunol. 2002. PMID: 12058653 Review. No abstract available.
Cited by
-
Toxoplasma gondii GRA15 DNA Vaccine with a Liposomal Nanocarrier Composed of an SS-Cleavable and pH-Activated Lipid-like Material Induces Protective Immunity against Toxoplasmosis in Mice.Vaccines (Basel). 2021 Dec 24;10(1):21. doi: 10.3390/vaccines10010021. Vaccines (Basel). 2021. PMID: 35062682 Free PMC article.
-
Differential immune response associated to malaria outcome is detectable in peripheral blood following Plasmodium yoelii infection in mice.PLoS One. 2014 Jan 23;9(1):e85664. doi: 10.1371/journal.pone.0085664. eCollection 2014. PLoS One. 2014. PMID: 24465641 Free PMC article.
-
Immunogenicity, protective efficacy and safety of a recombinant DNA vaccine encoding truncated Plasmodium yoelii sporozoite asparagine-rich protein 1 (PySAP1).Hum Vaccin Immunother. 2013 May;9(5):1104-11. doi: 10.4161/hv.23688. Epub 2013 Jan 28. Hum Vaccin Immunother. 2013. PMID: 23357857 Free PMC article.
-
The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya.J Glob Infect Dis. 2013 Oct;5(4):131-7. doi: 10.4103/0974-777X.122001. J Glob Infect Dis. 2013. PMID: 24672173 Free PMC article.
-
Augmented particle trapping and attenuated inflammation in the liver by protective vaccination against Plasmodium chabaudi malaria.Malar J. 2009 Apr 2;8:54. doi: 10.1186/1475-2875-8-54. Malar J. 2009. PMID: 19341445 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials